Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

Overview of attention for article published in Drugs, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 21 X posts from 19 X users, with an upper bound of 103,336 followers.

"Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations." https://t.co/sEwSWz1AUy

Review on meropenem-vaborbactam and imipenem-relebactam Check out this one! https://t.co/m2lTcpqOAP @GSHPofficial #gshpsummer2018

ICYMI: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. https://t.co/H8H6DsImXO https://t.co/Vpj58aCXU5

RT @Pro_antibiotic: "Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations" https://t.co/A…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.